1.
The Pharmaceutical Research and Mechanism Exploration of Recombinant Allophycocyanin (rAPC)
抗肿瘤新药重组别藻蓝蛋白（雷普克）的药学研究及抗肿瘤机理探索
2.
Pharmacokinetics Study of a Novel Antitumor Drug, Tetrazanbigen;
抗肿瘤新药德氮吡格的药物代谢动力学研究
3.
Preparation, Characterization, and Pharmacodynamics of a Novel Anti-tumor Drug, Ga(III)-EDTMP;
抗肿瘤新药Ga(III)-EDTMP的制备、表征和药效学研究
4.
A Survey on the Mechanism of a New Antitumor Drug TNBG with Novel Configuration;
创新构型抗肿瘤新药德氮吡格的作用机制探讨
5.
Proteomics Analysis of Creative New Antitumor Drug of TNBG;
抗肿瘤新药德氮吡格的蛋白质组学研究
6.
Studies on Toxicity and Toxicokinetics of UTD1, a New Anti-Cancer Drug;
抗肿瘤新药UTD1的毒理学和毒代动力学研究
7.
Toxicologic Characteristics and Toxicity Mechanisms of DATR, a New Investigational Antitumor Drug;
抗肿瘤新药DATR的毒理学特征及其毒性机制
8.
Chemical Structure of a Novel Antitumor Drug-Pemetrexed by NMR Techniques;
抗肿瘤新药培美曲塞的核磁共振谱研究
9.
A Feasible Mode for Independent Innovation of New Drug in China--A Case Study on Anti-tumor New Drug H101;
我国新药自主创新一种可行模式研究——以抗肿瘤新药“H101”为例
10.
Pharmacokinetic of Z24, a Potential Antitumor Agent;
新型抗肿瘤药Z24药代动力学研究
11.
A New Synthetic Procedure for Antineoplastic Agent Combretastatin A-4;
抗肿瘤药物Combretastatin A-4新合成方法
12.
A new synthetic method of nedaplatin-a platinum-based antitumor drug
铂类抗肿瘤药物奈达铂的新合成方法
13.
clinical pharmacology of anti-neoplastic drugs
抗肿瘤药物临床药理学
14.
Discovery of anti MDR-tumor agent PHⅡ-7:Synthesis and genomics approach to its mode of action
抗耐药肿瘤新药PHII-7的合成与作用机理研究
15.
Synthesis of Antitumor Agent Pomalidomide
抗肿瘤药Pomalidomide的合成
16.
Synthesis of Antitumor Agent Vorinostat
抗肿瘤药Vorinostat的合成
17.
Utilization of Antineoplastic Drugs and Adjuvant Drugs in Our Hospital During the Period 2005～2008
我院2005～2008年抗肿瘤药及抗肿瘤辅助药利用分析
18.
Study on Controlled Release of Anticancer-drug Lomustine & Vincristine;
抗肿瘤药物洛莫司汀、长春新碱控制释放的研究